Silvia Fargion Selected Research

Ferritins (Ferritin)

1/2021	Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with NAFLD.
1/2020	Impact of natural neuromedin-B receptor variants on iron metabolism.
1/2018	Hepatic iron is the major determinant of serum ferritin in NAFLD patients.
4/2016	Role of Serum Uric Acid and Ferritin in the Development and Progression of NAFLD.
1/2015	Iron Stores, Hepcidin, and Aortic Stiffness in Individuals with Hypertension.
9/2014	Juvenile hemochromatosis associated with heterozygosity for novel hemojuvelin mutations and with unknown cofactors.
3/2014	A randomized trial of iron depletion in patients with nonalcoholic fatty liver disease and hyperferritinemia.
2/2013	The A736V TMPRSS6 polymorphism influences hepcidin and iron metabolism in chronic hemodialysis patients: TMPRSS6 and hepcidin in hemodialysis.
12/2012	Effect of the A736V TMPRSS6 polymorphism on the penetrance and clinical expression of hereditary hemochromatosis.
12/2012	CYBRD1 as a modifier gene that modulates iron phenotype in HFE p.C282Y homozygous patients.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Silvia Fargion Research Topics

Disease

56	Non-alcoholic Fatty Liver Disease 02/2022 - 02/2002
44	Fibrosis (Cirrhosis) 11/2020 - 05/2004
22	Insulin Resistance 01/2018 - 02/2002
17	Iron Overload 01/2021 - 01/2003
16	Fatty Liver 10/2021 - 02/2002
15	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021 - 08/2007
15	Hemochromatosis (Bronze Diabetes) 01/2020 - 06/2002
14	Liver Diseases (Liver Disease) 01/2021 - 08/2004
13	Inflammation (Inflammations) 01/2021 - 08/2004
12	Hepatocellular Carcinoma (Hepatoma) 10/2020 - 05/2004
11	Chronic Hepatitis C 10/2021 - 05/2002
10	Hyperferritinemia 01/2021 - 10/2003
9	Infections 12/2017 - 07/2005
9	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2014 - 06/2007
6	Siderosis 01/2021 - 02/2002
5	Hepatitis 12/2017 - 08/2004
5	Chronic Hepatitis (Chronic Active Hepatitis) 05/2008 - 05/2004
4	Type 2 Diabetes Mellitus (MODY) 11/2020 - 02/2012
4	Atherosclerosis 01/2019 - 03/2011
4	Obesity 06/2018 - 06/2007
4	Hypertension (High Blood Pressure) 01/2017 - 09/2008
4	Alcoholic Fatty Liver 01/2017 - 08/2012
4	beta-Thalassemia (Cooley's Anemia) 09/2014 - 08/2007
3	Anemia 01/2021 - 08/2009
3	Abdominal Obesity 01/2017 - 06/2011
3	Hyperglycemia 02/2015 - 05/2012
2	Neoplasms (Cancer) 10/2021 - 10/2020
2	Dyslipidemias (Dyslipidemia) 01/2019 - 07/2014
2	Cryptogenic Cirrhosis 01/2017 - 02/2013
2	Chronic Hepatitis B 10/2013 - 02/2013
2	Iron Deficiencies 02/2013 - 02/2010
2	Alcoholism (Alcohol Abuse) 12/2012 - 01/2008
2	Glucose Intolerance 06/2011 - 02/2002
1	Weight Gain 01/2022
1	Dysbiosis 10/2021
1	Liver Neoplasms (Liver Cancer) 10/2021
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2021
1	Thalassemia 01/2021
1	Cholelithiasis 01/2020
1	Hepatomegaly 01/2020

Drug/Important Bio-Agent (IBA)

40	IronIBA 01/2021 - 05/2002
21	Ferritins (Ferritin)IBA 01/2021 - 10/2003
15	EnzymesIBA 01/2020 - 02/2002
14	HepcidinsIBA 01/2020 - 08/2007
12	LipidsIBA 10/2021 - 02/2010
11	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 06/2002
10	Transferrin (beta 2 Transferrin)IBA 01/2021 - 01/2003
9	Phospholipases (Phospholipase)IBA 11/2020 - 04/2010
9	Proteins (Proteins, Gene)FDA Link 10/2020 - 05/2008
8	Triglycerides (Triacylglycerol)IBA 01/2019 - 09/2008
7	CytokinesIBA 02/2022 - 02/2002
7	InterferonsIBA 12/2017 - 05/2002
7	Alanine Transaminase (SGPT)IBA 03/2016 - 09/2008
6	Transaminases (Aminotransferases)IBA 01/2022 - 09/2008
5	Messenger RNA (mRNA)IBA 06/2018 - 10/2003
5	Insulin (Novolin)FDA Link 10/2015 - 06/2007
4	AdiponectinIBA 01/2018 - 08/2012
4	Hormones (Hormone)IBA 10/2016 - 01/2012
3	Antiviral Agents (Antivirals)IBA 10/2021 - 03/2011
3	Ribavirin (Virazole)FDA LinkGeneric 01/2014 - 01/2006
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2013 - 02/2002
3	AntioxidantsIBA 02/2010 - 07/2005
3	LDL CholesterolIBA 01/2008 - 12/2005
2	metal transporting protein 1 (ferroportin)IBA 01/2021 - 11/2010
2	CarbohydratesIBA 11/2020 - 10/2011
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 11/2020 - 09/2010
2	ApolipoproteinsIBA 11/2020 - 07/2010
2	FructoseIBA 11/2020 - 01/2017
2	Peptides (Polypeptides)IBA 10/2020 - 07/2014
2	Sterol Esterase (Hormone-Sensitive Lipase)IBA 12/2019 - 01/2017
2	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 01/2006
2	CholesterolIBA 06/2018 - 09/2015
2	AnticoagulantsIBA 01/2018 - 07/2014
2	Telomerase (Telomerase Reverse Transcriptase)IBA 08/2017 - 02/2013
2	Methionine (L-Methionine)FDA Link 01/2017 - 04/2010
2	Insulin ReceptorIBA 01/2017 - 03/2008
2	Biomarkers (Surrogate Marker)IBA 04/2016 - 06/2011
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2016 - 09/2015
2	AdipokinesIBA 10/2015 - 06/2013
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 03/2014 - 06/2012
2	TransferasesIBA 03/2014 - 03/2011
2	adiponutrinIBA 10/2010 - 04/2010
2	Deferoxamine (Desferal)FDA LinkGeneric 02/2010 - 03/2008
1	Bevacizumab (Avastin)FDA Link 02/2022
1	atezolizumabIBA 02/2022
1	Ceruloplasmin (Ferroxidase)IBA 01/2021
1	MicronutrientsIBA 11/2020
1	FatsIBA 11/2020
1	VitaminsIBA 11/2020
1	NeurotensinIBA 10/2020
1	Neurotensin Receptors (Neurotensin Receptor)IBA 10/2020
1	Bombesin Receptors (Bombesin Receptor)IBA 01/2020
1	GlycosphingolipidsIBA 01/2020
1	Glucosylceramidase (Glucocerebrosidase)IBA 01/2020

Therapy/Procedure

16	Therapeutics 02/2022 - 05/2002
3	Liver Transplantation 02/2013 - 05/2004
2	Renal Dialysis (Hemodialysis) 08/2009 - 01/2007
1	Immunotherapy 02/2022
1	Mediterranean Diet 01/2022
1	Ambulatory Care (Outpatient Care) 11/2020